PTX-022 (QTORIN Sirolimus)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for PTX-022 (QTORIN Sirolimus), covering 2025-01-17 to 2025-01-17. Get the full timeline:
Most recent: Clinical Trial Update: Study Evaluating the Safety and Efficacy of PTX-022 (QTORIN Sirolimus) in the Treatment of Microcystic Lymphatic Malformations [Phase 2]